2023年，赛国生物再次取得依科赛/ExCell Bio一级授权代理书。

      依科赛生物(ExCell Bio)创立于2013年，以“加快生命科技应用，造福百姓健康”为使命，致力于解决生物医药卡脖子、实现关键原料国产化，现已成为中国生物医药上游核心原材料的领军企业之一。公司是国家高新技术企业，国家级专精特新小巨人企业，中国首家国际血清行业协会（ISIA）会员单位，江苏省生物制药、细胞治疗等领域用CD无血清培养基工程研究中心。

      公司当前聚焦无血清培养基、胎牛血清和鉴定试剂等三大产品板块，为生物药、细胞与基因治疗、基础科学研究客户提供国际品质的产品与服务。公司依托国际化和专业化的研发技术团队、质量和生产团队以及商业化团队，持续创新，追求卓越，在不断优化产品性能的同时，确保可靠的质量和稳定的供应，全面赋能生物医药产业的快速健康发展，打造细胞培养“中国芯”产品。

     公司目前已服务超过10,000家客户遍布高校、研究所、医院、生物制药、基因测序等企业客户。在上海、北京、广州、深圳、香港等全国主要城市设有管理和营销中心，并在美国、澳大利亚和乌拉圭设有分公司。

      In 2023, Saiguo Biotech once again obtained the first-level authorization letter of ExCell Bio.

      Founded in 2013, with the mission of "accelerating the application of life science and technology and benefiting the health of the people", ExCell Bio is committed to solving the neck of biomedicine and realizing the localization of key raw materials, and has now become one of the leading enterprises in China's biomedical upstream core raw materials. The company is a national high-tech enterprise, a national specialized and special new small giant enterprise, China's first member unit of the International Serum Industry Association (ISIA), and a CD serum-free media engineering research center in the fields of biopharmaceuticals and cell therapy in Jiangsu Province.

      The company currently focuses on three major product segments, including serum-free culture media, fetal bovine serum and identification reagents, and provides international quality products and services for customers in biological drugs, cell and gene therapy, and basic scientific research. Relying on the international and professional R & D technical team, quality and production team and commercialization team, the company continues to innovate, pursues excellence, ensures reliable quality and stable supply while continuously optimizing product performance, fully empowers the rapid and healthy development of the biomedical industry, and creates cell culture "Chinese core" products.

     At present, the company has served more than 10,000 customers in universities, research institutes, hospitals, biopharmaceuticals, gene sequencing and other enterprise customers. It has management and marketing centers in major cities such as Shanghai, Beijing, Guangzhou, Shenzhen and Hong Kong, and branches in the United States, Australia and Uruguay.

【2023/1/3 12:40:02】